abstract |
The invention relates to compounds having formula (I). Said compounds have an affinity for bradykinin receptors with a selectivity for B1 receptors and they can be used to prepare medicaments that are intended to treat or prevent persistent or chronic inflammatory diseases and inflammation pathologies. |